At 0.5 hours postdose , plasma concentrations of ticagrelor and AR-C124910XX were higher with crushed tablets administered orally ( 148.6 ng/mL and 13.0 ng/mL , respectively ) or via nasogastric tube ( 264.6 ng/mL and 28.6 ng/mL , respectively ) compared with whole-tablet administration ( 33.3 ng/mL and 5.2 ng/mL , respectively ) .